QQ客服 官方微博 反馈留言

	Co-delivery doxorubicin and silybin for anti-hepatoma via enhanced oral hepatic-targeted efficiency
	Li, Ying; Yang, Dandan; Wang, Yian; Li, Zhan; Zhu, Chunyan
	2019
卷号	14页码:301-315
关键词	doxorubicin silybin hepatic targeting via oral administration cholic acid transporter anti-hepatoma biodistribution in vivo
ISSN号	1178-2013
DOI	10.2147/IJN.S187888
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6345274
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Li, Ying,Yang, Dandan,Wang, Yian,et al. Co-delivery doxorubicin and silybin for anti-hepatoma via enhanced oral hepatic-targeted efficiency[J],2019,14:301-315.
APA	Li, Ying,Yang, Dandan,Wang, Yian,Li, Zhan,&Zhu, Chunyan.(2019).Co-delivery doxorubicin and silybin for anti-hepatoma via enhanced oral hepatic-targeted efficiency.,14,301-315.
MLA	Li, Ying,et al."Co-delivery doxorubicin and silybin for anti-hepatoma via enhanced oral hepatic-targeted efficiency".14(2019):301-315.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。